Fresh Tracks Therapeutics, Inc. (FRTX)
- Previous Close
0.9201 - Open
0.9201 - Bid --
- Ask --
- Day's Range
0.9100 - 0.9201 - 52 Week Range
0.4900 - 1.1000 - Volume
1,893 - Avg. Volume
16,092 - Market Cap (intraday)
5.444M - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0600 - Earnings Date May 13, 2024 - May 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
ir.frtx.comRecent News: FRTX
Performance Overview: FRTX
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FRTX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FRTX
Valuation Measures
Market Cap
5.44M
Enterprise Value
-3.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.61
Price/Book (mrq)
0.55
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-71.12%
Return on Assets (ttm)
-36.37%
Return on Equity (ttm)
-66.50%
Revenue (ttm)
8.01M
Net Income Avi to Common (ttm)
-5.69M
Diluted EPS (ttm)
-1.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
10.87M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.67M
Research Analysis: FRTX
Company Insights: FRTX
FRTX does not have Company Insights